• Je něco špatně v tomto záznamu ?

Stereotactic Radiosurgery for Olfactory Groove Meningiomas: An International, Multicenter Study

A. Bunevicius, J. Ahn, S. Fribance, S. Peker, B. Hergunsel, D. Sheehan, K. Sheehan, AM. Nabeel, WA. Reda, SR. Tawadros, K. Abdelkarim, AMN. El-Shehaby, RM. Emad, T. Chytka, R. Liscak, RM. Alvarez, NM. Moreno, AM. Langlois, D. Mathieu, CC. Lee,...

. 2021 ; 89 (5) : 784-791. [pub] 20211013

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc22003467

BACKGROUND: Stereotactic radiosurgery (SRS) is increasingly considered for selected olfactory groove meningiomas (OGMs). OBJECTIVE: To investigate the safety and efficacy of SRS for OGMs. METHODS: From 20 institutions participating in the International Radiosurgery Research Foundation, we pooled patients who underwent SRS for histologically confirmed or radiologically suspected WHO grade I OGMs and were followed for 6 mo or more after the SRS. RESULTS: In total, 278 (median age 57 yr) patients underwent SRS for histologically confirmed (29%) or radiologically suspected (71%) WHO grade I OGMs Median treatment volume was 4.60 cm3 (range: 0.12-27.3 cm3), median prescription dose was 12 Gy, and median dose to the olfactory nerve was 11.20 Gy. During median post-SRS imaging follow-up of 39 mo (range: 6-240 mo), 43% of patients had partial or marginal response, 54% of patients had stable disease, and 3% of patients experienced progression. During median post-SRS clinical follow-up of 51 mo (range: 6-240 mo), 36 (13%) patients experienced clinical and/or radiological adverse radiation events (AREs). Elevated risk of AREs was associated with larger OGM volume (P = .009) and pre-SRS peritumoral T2/fluid-attenuated inversion-recovery signal abnormalities (P < .001). After the SRS, olfaction remained stable, improved, or deteriorated in 90%, 8%, and 2% of patients, respectively. Complete post-SRS anosmia was predicted by partial/complete anosmia before the SRS (odds ratio [OR] = 83.125; 95% CI [24.589-281.01], P < .001) and prior resection of OGM (OR = 3.919; 95% CI [1.713-8.970], P = .001). CONCLUSION: SRS is associated with durable local control of the majority of OGM patients with acceptable safety profile. SRS allows preservation or improvement of olfactory function in the majority of OGM patients.

Administración de Servicios Médicos de Puerto Rico Centro Gamma Knife de Puerto Rico y El Caribe San Juan Puerto Rico

Clinical Oncology Department Ain Shams University Cairo Egypt

Department of Neurosurgery IRCCS Humanitas Research Hospital Rozzano Milan Italy

Department of Neurosurgery Koç University School of Medicine Istanbul Turkey

Department of Neurosurgery Na Homolce Hospital Prague Czech Republic

Department of Neurosurgery Neurological Institute Taipei Veteran General Hospital Taipei Taiwan

Department of Neurosurgery Post Graduate Institute of Medical Education and Research Chandigarh India

Department of Neurosurgery Université de Sherbrooke Centre de recherche du CHUS Sherbrooke Canada

Department of Neurosurgery University of Puerto Rico School of Medicine San Juan Puerto Rico

Department of Neurosurgery University of Southern California Los Angeles California USA

Department of Neurosurgery University of Virginia Charlottesville Virginia USA

Department of Radiation Oncology University of Southern California Los Angeles California USA

Division of Radiation Oncology University of Alberta Edmonton Canada

Gamma Knife Center Cairo Nasser Institute Hospital Cairo Egypt

Gamma Knife Center Jewish Hospital Mayfield Clinic Cincinnati Ohio USA

Gamma Knife Radiology Department Dominican Gamma Knife Center and CEDIMAT Santo Domingo Dominican Republic

Hospital Ruber Internacional Madrid Spain

Neurosurgery Department Ain Shams University Cairo Egypt

Neurosurgery Department Benha University Qalubya Egypt

Radiation Oncology Department National Cancer Institute Cairo University Cairo Egypt

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003467
003      
CZ-PrNML
005      
20220127150212.0
007      
ta
008      
220113s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1093/neuros/nyab291 $2 doi
035    __
$a (PubMed)34383951
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Bunevicius, Adomas $u Department of Neurosurgery, University of Virginia, Charlottesville, Virginia, USA
245    10
$a Stereotactic Radiosurgery for Olfactory Groove Meningiomas: An International, Multicenter Study / $c A. Bunevicius, J. Ahn, S. Fribance, S. Peker, B. Hergunsel, D. Sheehan, K. Sheehan, AM. Nabeel, WA. Reda, SR. Tawadros, K. Abdelkarim, AMN. El-Shehaby, RM. Emad, T. Chytka, R. Liscak, RM. Alvarez, NM. Moreno, AM. Langlois, D. Mathieu, CC. Lee, HC. Yang, M. Tripathi, RE. Warnick, H. Speckter, C. Albert, P. Picozzi, A. Franzini, L. Attuati, BA. Strickland, G. Zada, EL. Chang, CE. Feliciano Valls, CH. Carbini, S. Patel, J. Sheehan
520    9_
$a BACKGROUND: Stereotactic radiosurgery (SRS) is increasingly considered for selected olfactory groove meningiomas (OGMs). OBJECTIVE: To investigate the safety and efficacy of SRS for OGMs. METHODS: From 20 institutions participating in the International Radiosurgery Research Foundation, we pooled patients who underwent SRS for histologically confirmed or radiologically suspected WHO grade I OGMs and were followed for 6 mo or more after the SRS. RESULTS: In total, 278 (median age 57 yr) patients underwent SRS for histologically confirmed (29%) or radiologically suspected (71%) WHO grade I OGMs Median treatment volume was 4.60 cm3 (range: 0.12-27.3 cm3), median prescription dose was 12 Gy, and median dose to the olfactory nerve was 11.20 Gy. During median post-SRS imaging follow-up of 39 mo (range: 6-240 mo), 43% of patients had partial or marginal response, 54% of patients had stable disease, and 3% of patients experienced progression. During median post-SRS clinical follow-up of 51 mo (range: 6-240 mo), 36 (13%) patients experienced clinical and/or radiological adverse radiation events (AREs). Elevated risk of AREs was associated with larger OGM volume (P = .009) and pre-SRS peritumoral T2/fluid-attenuated inversion-recovery signal abnormalities (P < .001). After the SRS, olfaction remained stable, improved, or deteriorated in 90%, 8%, and 2% of patients, respectively. Complete post-SRS anosmia was predicted by partial/complete anosmia before the SRS (odds ratio [OR] = 83.125; 95% CI [24.589-281.01], P < .001) and prior resection of OGM (OR = 3.919; 95% CI [1.713-8.970], P = .001). CONCLUSION: SRS is associated with durable local control of the majority of OGM patients with acceptable safety profile. SRS allows preservation or improvement of olfactory function in the majority of OGM patients.
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    12
$a meningeální nádory $x diagnostické zobrazování $x radioterapie $x chirurgie $7 D008577
650    12
$a meningeom $x diagnostické zobrazování $x radioterapie $x chirurgie $7 D008579
650    _2
$a lidé středního věku $7 D008875
650    12
$a radiochirurgie $x škodlivé účinky $7 D016634
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Ahn, Jungeun $u Department of Neurosurgery, University of Virginia, Charlottesville, Virginia, USA
700    1_
$a Fribance, Sarah $u Department of Neurosurgery, University of Virginia, Charlottesville, Virginia, USA
700    1_
$a Peker, Selcuk $u Department of Neurosurgery, Koç University School of Medicine, Istanbul, Turkey
700    1_
$a Hergunsel, Batu $u Department of Neurosurgery, Koç University School of Medicine, Istanbul, Turkey
700    1_
$a Sheehan, Darrah $u Department of Neurosurgery, University of Virginia, Charlottesville, Virginia, USA
700    1_
$a Sheehan, Kimball $u Department of Neurosurgery, University of Virginia, Charlottesville, Virginia, USA
700    1_
$a Nabeel, Ahmed M $u Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo, Egypt $u Neurosurgery Department, Benha University, Qalubya, Egypt
700    1_
$a Reda, Wael A $u Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo, Egypt $u Neurosurgery Department, Ain Shams University, Cairo, Egypt
700    1_
$a Tawadros, Sameh R $u Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo, Egypt $u Neurosurgery Department, Ain Shams University, Cairo, Egypt
700    1_
$a Abdelkarim, Khaled $u Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo, Egypt $u Clinical Oncology Department, Ain Shams University, Cairo, Egypt
700    1_
$a El-Shehaby, Amr M N $u Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo, Egypt $u Neurosurgery Department, Ain Shams University, Cairo, Egypt
700    1_
$a Emad, Reem M $u Gamma Knife Center Cairo, Nasser Institute Hospital, Cairo, Egypt $u Radiation Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt
700    1_
$a Chytka, Tomas $u Department of Neurosurgery, Na Homolce Hospital, Prague, Czech Republic
700    1_
$a Liscak, Roman $u Department of Neurosurgery, Na Homolce Hospital, Prague, Czech Republic
700    1_
$a Alvarez, Roberto Martínez $u Hospital Ruber Internacional, Madrid, Spain
700    1_
$a Moreno, Nuria Martínez $u Hospital Ruber Internacional, Madrid, Spain
700    1_
$a Langlois, Anne-Marie $u Department of Neurosurgery, Université de Sherbrooke, Centre de recherche du CHUS, Sherbrooke, Canada
700    1_
$a Mathieu, David $u Department of Neurosurgery, Université de Sherbrooke, Centre de recherche du CHUS, Sherbrooke, Canada
700    1_
$a Lee, Cheng-Chia $u Department of Neurosurgery, Neurological Institute, Taipei Veteran General Hospital, Taipei, Taiwan
700    1_
$a Yang, Huai-Che $u Department of Neurosurgery, Neurological Institute, Taipei Veteran General Hospital, Taipei, Taiwan
700    1_
$a Tripathi, Manjul $u Department of Neurosurgery, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
700    1_
$a Warnick, Ronald E $u Gamma Knife Center, Jewish Hospital, Mayfield Clinic, Cincinnati, Ohio, USA
700    1_
$a Speckter, Herwin $u Gamma Knife, Radiology Department Dominican Gamma Knife Center and CEDIMAT, Santo Domingo, Dominican Republic
700    1_
$a Albert, Camilo $u Gamma Knife, Radiology Department Dominican Gamma Knife Center and CEDIMAT, Santo Domingo, Dominican Republic
700    1_
$a Picozzi, Piero $u Department of Neurosurgery, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
700    1_
$a Franzini, Andrea $u Department of Neurosurgery, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
700    1_
$a Attuati, Luca $u Department of Neurosurgery, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
700    1_
$a Strickland, Ben A $u Department of Neurosurgery, University of Southern California, Los Angeles, California, USA
700    1_
$a Zada, Gabriel $u Department of Neurosurgery, University of Southern California, Los Angeles, California, USA
700    1_
$a Chang, Eric L $u Department of Radiation Oncology, University of Southern California, Los Angeles, California, USA
700    1_
$a Feliciano Valls, Caleb E $u Department of Neurosurgery, University of Puerto Rico, School of Medicine, San Juan, Puerto Rico
700    1_
$a Carbini, Carlos H $u Administración de Servicios Médicos de Puerto Rico, Centro Gamma Knife de Puerto Rico y El Caribe, San Juan, Puerto Rico
700    1_
$a Patel, Samir $u Division of Radiation Oncology, University of Alberta, Edmonton, Canada
700    1_
$a Sheehan, Jason $u Department of Neurosurgery, University of Virginia, Charlottesville, Virginia, USA
773    0_
$w MED00003511 $t Neurosurgery $x 1524-4040 $g Roč. 89, č. 5 (2021), s. 784-791
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34383951 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127150209 $b ABA008
999    __
$a ok $b bmc $g 1751043 $s 1154616
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 89 $c 5 $d 784-791 $e 20211013 $i 1524-4040 $m Neurosurgery $n Neurosurgery $x MED00003511
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Možnosti archivace